241 related articles for article (PubMed ID: 25156182)
1. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
2. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
4. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.
Weinstein SJ; Mondul AM; Kopp W; Rager H; Virtamo J; Albanes D
Int J Cancer; 2013 Jun; 132(12):2940-7. PubMed ID: 23180681
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
7. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study.
Weinstein SJ; Stolzenberg-Solomon RZ; Kopp W; Rager H; Virtamo J; Albanes D
Cancer Res; 2012 Mar; 72(5):1190-8. PubMed ID: 22232734
[TBL] [Abstract][Full Text] [Related]
8. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.
Mondul AM; Weinstein SJ; Horst RL; Purdue M; Albanes D
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1222-5. PubMed ID: 22623707
[TBL] [Abstract][Full Text] [Related]
9. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Virtamo J; Albanes D
Br J Cancer; 2012 Oct; 107(9):1589-94. PubMed ID: 22990651
[TBL] [Abstract][Full Text] [Related]
10. Serum vitamin D, vitamin D binding protein, and lung cancer survival.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
Lung Cancer; 2014 Dec; 86(3):297-303. PubMed ID: 25456734
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.
Song M; Konijeti GG; Yuan C; Ananthakrishnan AN; Ogino S; Fuchs CS; Giovannucci EL; Ng K; Chan AT
Cancer Prev Res (Phila); 2016 Aug; 9(8):664-72. PubMed ID: 27246684
[TBL] [Abstract][Full Text] [Related]
12. Association of thyroid cancer risk with plasma 25-hydroxyvitamin D and vitamin D binding protein: a case-control study in China.
Hu MJ; Niu QS; Wu HB; Lu XL; Wang L; Tong XR; Huang F
J Endocrinol Invest; 2020 Jun; 43(6):799-808. PubMed ID: 31863361
[TBL] [Abstract][Full Text] [Related]
13. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
14. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
[TBL] [Abstract][Full Text] [Related]
16. Total and Free Circulating Vitamin D and Vitamin D-Binding Protein in Relation to Colorectal Cancer Risk in a Prospective Study of African Americans.
Andersen SW; Shu XO; Cai Q; Khankari NK; Steinwandel MD; Jurutka PW; Blot WJ; Zheng W
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1242-1247. PubMed ID: 28483970
[No Abstract] [Full Text] [Related]
17. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
[TBL] [Abstract][Full Text] [Related]
18. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Vitamin D Status and Risk of ESRD.
Rebholz CM; Grams ME; Lutsey PL; Hoofnagle AN; Misialek JR; Inker LA; Levey AS; Selvin E; Hsu CY; Kimmel PL; Vasan RS; Eckfeldt JH; Coresh J;
Am J Kidney Dis; 2016 Feb; 67(2):235-42. PubMed ID: 26475393
[TBL] [Abstract][Full Text] [Related]
20. Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer.
Ying HQ; Sun HL; He BS; Pan YQ; Wang F; Deng QW; Chen J; Liu X; Wang SK
Sci Rep; 2015 Jan; 5():7956. PubMed ID: 25609140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]